Roy Buchanan
Stock Analyst at JMP Securities
(0.52)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PYPD PolyPid | Maintains: Market Outperform | 16 14 | 3.67 | 281.47% | 2 | Jun 17, 2025 | |
ENTA Enanta Pharma | Maintains: Market Outperform | 23 24 | 7.08 | 238.98% | 13 | Jun 3, 2025 | |
CDTX Cidara Therapeutics | Reiterates: Market Outperform | 47 47 | 44.83 | 4.84% | 5 | Jun 2, 2025 | |
CVAC CureVac | Reiterates: Market Outperform | 10 10 | 5.38 | 85.87% | 9 | May 28, 2025 | |
DVAX Dynavax Technologies | Maintains: Market Outperform | 33 31 | 9.73 | 218.6% | 6 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 5 2 | 1.07 | 86.92% | 9 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 18 18 | 1.94 | 827.84% | 3 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 7 4 | 1.04 | 284.62% | 3 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 23 14 | 0.68 | 1958.82% | 1 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 33 33 | 6.11 | 440.1% | 1 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 24 7 | 1.27 | 451.18% | 2 | Nov 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 4 5 | 3.42 | 46.2% | 5 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Jul 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 443 448 | 540.88 | -17.17% | 2 | Mar 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 14 16 | 16.6 | -3.61% | 1 | Mar 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Feb 16, 2023 |